Disease Focus: Diabetes
Diabetes: Progress toward stem cell therapies, a Live Google Hangout
California’s Stem Cell Agency (CIRM) hosted a live Google Hangout about recent progress in stem cell based strategies for diabetes therapies. The speakers included: Francisco Prieto, MD – CIRM’s diabetes patient advocate governing board member. Dr. Prieto is a practicing physician and researcher who has been active in diabetes care, patient and professional education […]
Ron Piran, Sanford-Burnham – CIRM Stem Cell #SciencePitch
Eugene Brandon, Viacyte, Inc. – CIRM Stem Cell #SciencePitch
Diabetes: Progress and Promise in Stem Cell Research
CIRM has funded the Diabetes Disease Team led by scientists at ViaCyte, Inc., UCSF, and the La Jolla Institute for Allergy and Immunology. This team aims to bring an embryonic stem cell based therapy for diabetes to clinical trials. For more info, see our diabetes fact sheet.
Diabetes: Advancing Stem Cell Therapies – 2011 CIRM Grantee Meeting
Eugene Brandon speaks at the 2011 CIRM Grantee Meeting about Viacyte’s efforts to develop a stem cell based treatment for diabetes. CIRM has awarded Viacyte $26 million to support their diabetes program which aims to bring a therapy to clinical trials. Brandon is director of strategic relations and project management at Viacyte, Inc.
Alan Lewis Talks About Getting an Embryonic Stem Cell-Based Therapy to Patients
Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is the former president and CEO of Novocell (now ViaCyte), a La Jolla-based company that has been developing a potential therapy for diabetes. Novocell has several CIRM grants to develop a stem […]
Spotlight on Type 1 Diabetes: Welcoming Remarks
Robert Klein, J.D. gave the welcoming remarks for the “Spotlight on Juvenile Diabetes”, an educational event presented at the CIRM Governing Board meeting on September 25, 2008. Klein is Chair of the CIRM Governing Board and President of Klein Financial Corporation. The CIRM-hosted event was presented at the University of California, San Diego in partnership […]
Spotlight on Type 1 Diabetes: Seminar by Ed Baetge, Ph.D.
Ed Baetge, Ph.D. spoke at the Spotlight on Juvenile Diabetes, an educational event presented at the CIRM Governing Board meeting on September 25, 2008. Baetge discussed Novocell, Inc.’s (now ViaCyte) efforts to generate replacement pancreatic beta islet cells from human embryonic stem cells for the development of cell-based diabetes therapies. Novocell Inc. has two […]
Spotlight on Type 1 Diabetes: Seminar by Peter Butler, M.D.
Peter Butler, M.D. spoke at the Spotlight on Juvenile Diabetes, an educational event presented at the CIRM Governing Board meeting on September 25, 2008. Butler summarized normal glucose metabolism, explained how loss of pancreatic beta islet cells leads to diabetes, and presented evidence for beta cell regeneration in adults. Butler is the Director of the […]
Spotlight on Type 1 Diabetes: Seminar by Joelle Johnson
Joelle Johnson spoke at the Spotlight on Juvenile Diabetes, an educational event presented at the CIRM Governing Board Meeting on September 25, 2008. Johnson talked about her diabetes diagnosis in 2004 and reflected upon the impact of diabetes on her daily life. Johnson lives in Los Angeles where she works for ABC Television. Johnson […]